Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
about
Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation.Effects of shear on proteins in solution.Aggregates in monoclonal antibody manufacturing processes.Protein particulate detection issues in biotherapeutics development--current status.Immunogenicity of therapeutic proteins: influence of aggregation.Protein/Peptide Aggregation and Amyloidosis on Biointerfaces.Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.Control of protein particle formation during ultrafiltration/diafiltration through interfacial protection.Protein G, protein A and protein A-derived peptides inhibit the agitation induced aggregation of IgG.Inhibited fragmentation of mAbs in buffered ionic liquids.High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.Analytical comparability study of recombinant monoclonal antibody therapeutics.Forced degradation of recombinant monoclonal antibodies: A practical guide.Recognition of polymer side chains by cyclodextrins
P2860
Q30422151-E590FC5A-C84F-48B0-98A3-08C48DFE5106Q37619232-4E272A9A-B0B1-4DA4-946F-CD10F9B0B94CQ37810518-FCB09A84-0138-419A-B19D-13637466765DQ37863609-8CC3BD2C-A4A8-4B38-8BC4-B3BC6E1649CBQ38008257-30F4A2C5-09B3-4B86-ADFD-E837B517A6E9Q38126938-3847C43E-BCA6-4B18-8156-2EC4B90788E9Q38647304-66FF2031-BF44-4C85-A930-2A045F27CCADQ38841187-24845F83-EF7A-4544-9BEC-F880A4DEE8E6Q40119636-31001CDB-895A-4C26-9111-EB7244A99D55Q41813346-D6D25899-CE79-4E07-8DEA-1B7C8D174F0EQ41907182-139AF53D-F0C2-4C6E-8CB2-E7F7AA33B256Q41987513-E358C048-2812-4F0B-876B-BD1A0CF53496Q42009419-63BDBA96-10BF-49CA-9244-2B8295D005ADQ42594193-01821FCC-578A-4C05-B018-319C119C1537Q50436890-26573F96-FE00-4F56-BA1F-AA20312D8C19Q50542693-CE0F0225-17BE-42B6-9AAA-C64263D9EA63Q52669512-4A25C985-3E6F-48A8-906D-B48790F541B8Q53090989-E094D7F6-8800-4DD1-9AA1-DE023E048F1AQ57367208-55F65AD9-0545-4795-8764-8E1DC19D20A7
P2860
Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@en
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@nl
type
label
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@en
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@nl
prefLabel
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@en
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@nl
P2093
P356
P1476
Inhibition of agitation-induce ...... droxypropyl-beta-cyclodextrin.
@en
P2093
Gerhard Winter
John F Carpenter
P304
P356
10.1002/JPS.21931
P407
P577
2010-03-01T00:00:00Z